| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.7M | +605.3% |
| Cost of Revenue | $30.6M | +346.5% |
| Gross Profit | $20.2M | +5739.2% |
| R&D Expense | $20.9M | +67.3% |
| SG&A Expense | $44.5M | +159.4% |
| Operating Income | -$58.4M | -68.7% |
| Interest Expense | $933K | +0.0% |
| Pre-tax Income | -$132.9M | -249.6% |
| Income Tax | $488K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $550.7M | +1738.4% |
| Accounts Receivable | $22.4M | +328.0% |
| Inventory | $22.0M | +123.6% |
| Current Assets | $685.9M | +1343.4% |
| Total Assets | $1.13B | +933.4% |
| Current Liabilities | $141.8M | +180.4% |
| Total Liabilities | $661.2M | +797.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.7M | -15.8% |
| Capital Expenditures | $2.0M | +24.3% |
| Investing Cash Flow | -$260.1M | — |
| Financing Cash Flow | $862.7M | +1619.2% |
| Free Cash Flow | -$40.8M | -16.2% |
| -99.3% |
| Net Income | -$132.2M | -247.9% |
| EPS (Basic) | -$0.62 | -1.6% |
| EPS (Diluted) | -$0.62 | -1.6% |
| Stockholders' Equity |
| $437.8M |
| +2540.1% |